Genactis, Inc.

What Genactis, Inc. does

Genactis, Inc. is a private healthcare market research consultancy founded in 1998, operating dual capabilities for the pharmaceutical and biotech industry and for research agencies/CROs. The firm is headquartered at 27A Poland Street, London, with a wholly-owned German subsidiary (Genactis GmbH) in Cologne, and runs a panel supply operation that covers 40 countries. Its revenue rests on two service lines: (1) senior-led, project-based primary market research — qualitative and quantitative studies covering market understanding, patient journey, communication testing, launch readiness/tracking, and product perception — and (2) the Genactis Health Panel (GHP), a verified physician panel of 18,000+ actively practising, license-verified doctors across 43 specialties, sold on a per-complete basis with 2-3 week typical fieldwork turnaround.

The underlying technology is the GHP platform itself: a proprietary physician panel management system with license verification, regular re-verification, and quality checks, used both as internal recruitment infrastructure for Genactis' own research projects and as a sell-side sample product. Panel depth by country is biased toward core EU markets (Spain 4,900+, Italy 4,200+, France 4,100+, UK 2,600+, Germany 2,300+). Methodologically, every project is delivered by senior consultants with 10-15+ years of pharma research experience trained in behavioural economics and psychology, framing the offering as interpretive strategic insight rather than raw data collection.

Commercially, Genactis runs a B2B sales-led motion with no sales-team handoffs — prospects engage senior consultants directly via email, phone, or Wufoo web forms. Pricing is simple and transparent: quote-based for research services scoped per project, and per-complete for panel services with quality guarantees. The go-to-market targets two segments — pharmaceutical/biotech companies and research agencies/CROs — and is reinforced by memberships in EphMRA, BHBIA, and BVM industry associations, with no public financials, funding history, or investor disclosures in the source material.

Name

Genactis, Inc.

Legal name

Genactis, Inc.

Website

https://genactis.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Genactis, Inc. is a London-based healthcare market research consultancy serving pharmaceutical and biotech firms and research agencies/CROs with senior-led primary research and a verified 18,000+ physician panel (Genactis Health Panel) spanning 40 countries and 43 specialties.

Ownership category

akta.pro rank

Product category

Healthcare Market Research

NAICS

Marketing Research and Public Opinion Polling (541910), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

akta.pro secondary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

Keywords

• Healthcare market research
• Pharmaceutical primary research
• Physician panel access
• Behavioural science insights
• Biotech research consultancy

Headquarters

HQ city

Mougins

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Primary Market Research Services: Full-service qualitative and quantitative primary research designed and delivered by senior consultants. Projects include market understanding, patient journey studies, communication testing, launch readiness tracking, and product perception assessment. Revenue generated through project-based consulting fees.
2. Physician Panel & Fieldwork Services: Provision of verified physician sample for external research projects. Clients include research agencies and CROs. Priced on per-complete basis with transparent, simple pricing and quality guarantees. Typical turnaround 2-3 weeks.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Genactis is a boutique healthcare market research consultancy that delivers senior-led, end-to-end qualitative and quantitative primary research services to pharmaceutical and biotech companies, covering market understanding, patient journey analysis, communication testing, launch readiness tracking, and product perception assessment. Alongside its research practice, it operates the Genactis Health Panel (GHP) — a verified panel of 18,000+ actively practising, licence-verified physicians across 40 countries — sold as a physician sample and fieldwork service to research agencies and CROs on a per-complete pricing basis with typical 2–3 week turnaround.

Product overview

Genactis offers a dual-capability healthcare market research platform comprising two integrated services: Primary Market Research (senior-led, end-to-end qualitative and quantitative studies for pharmaceutical and biotech companies) and the Genactis Health Panel (GHP), a verified physician panel providing access to 18,000+ licence-verified physicians across 40 countries for research fieldwork. These capabilities are complemented by the Genactis Expert Network, which recruits healthcare professionals for participation in research projects. The research service serves pharmaceutical and biotech companies directly, while the panel and expert network serve research agencies, CROs, and the company's own research operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Primary Market Research Full-service qualitative and quantitative primary research for pharmaceutical and biotech companies, designed and delivered by senior consultants. Encompasses market understanding and patient journey studies, communication testing (positioning, message testing, creative concepts, detail aid), launch readiness and tracking (baseline awareness, post-launch adoption tracking, segmentation), and product perception/demand assessment (TPP evaluation, market sizing, value perception). Each engagement is scoped individually and produces clear 'so what' strategic recommendations.
• Genactis Health Panel (GHP) Proprietary physician panel platform providing verified sample of 18,000+ actively practising, license-verified doctors across 40 countries and 43 medical specialties (including Primary Care, oncology, haematology, cardiology, neurology, dermatology, and rare diseases), sold as physician sample and fieldwork services to research agencies, CROs, and Genactis' own research projects. Typical fieldwork turnaround is 2–3 weeks, with transparent per-complete pricing and quality guarantees.
• Genactis Expert Network Voluntary expert network enabling healthcare professionals to contribute expertise to pharmaceutical research exploring new therapies, treatment pathways, and the lifecycle of medicines. Participation is compensated fairly, voluntary, and confidential, with the network functioning as a recruitment channel supporting Genactis' research and panel operations.

Quantifiable outcome

• 2-3 week typical fieldwork turnaround; faster for standard specialties in core EU markets

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered minor.

• EphMRAminorOthersEuropean Pharmaceutical Market Research Association membership. Demonstrates adherence to industry standards and code of conduct for pharmaceutical market research in Europe.
• BHBIAminorOthersBritish Healthcare Business Intelligence Association membership. Supports best practices in healthcare business intelligence and market research in the UK.
• BVMminorOthersIndustry association membership supporting best practices in market research and business intelligence. Details of specific BVM organization not provided in source material.

Scale indicators10 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• CMI Media Group (Compas): CMI/Compas is a healthcare-focused media and market research agency serving pharma and biotech clients with primary research, media planning, and commercial analytics. Directly comparable to Genactis's primary market research services, with similar B2B pharma/biotech customer base.
• Schlesinger Group: Schlesinger Group operates qualitative and quantitative research panels and fieldwork services including healthcare panels. Comparable to Genactis in providing physician sample and fieldwork to research agencies and CROs, with similar per-complete pricing models.
• M3 Global Research: M3 Global Research runs one of the largest verified physician panels globally, providing online survey and qualitative fieldwork to market research clients. Closest direct competitor to Genactis's GHP physician panel offering, with overlapping methodology of license-verified doctor recruitment.
• AplusA Research & Analytics: AplusA is a boutique healthcare market research firm with strong European presence, particularly in Spain, France, Italy and Germany. Highly comparable to Genactis as a similarly-sized specialist serving pharma/biotech with primary research and physician fieldwork services.
• Medefield: Medefield provides physician fieldwork and panel services to the healthcare market research industry, with international coverage of verified doctors. Comparable to Genactis's panel/fieldwork arm serving research agencies and CROs with quality-verified physician sample.
• Hall & Partners: Hall & Partners is a brand and communications research agency with a dedicated health practice serving pharmaceutical and biotech clients. Directly comparable to Genactis in offering senior-led qualitative and quantitative research on physician decision-making, communication testing, and launch tracking.

Emerging players

• InCrowd: InCrowd is a tech-enabled micro-survey platform specializing in rapid physician market research, focused on HCPs across therapeutic areas. Comparable to Genactis in serving pharma market research needs but differentiated by a mobile-first, micro-survey delivery model rather than senior-led full-service research.
• Sermo: Sermo operates a physician social network and research platform that connects verified doctors with research opportunities. Partial overlap with Genactis's physician panel and fieldwork business, but focused on community-led research engagement rather than senior-led consulting.

Broad incumbents

• IQVIA: IQVIA is the largest healthcare data, analytics, and commercial services firm serving global pharma/biotech with primary market research alongside much broader offerings. Comparable to Genactis as a competitor for primary market research budgets, but operating at vastly greater scale with integrated RWE, commercial, and consulting capabilities.
• Kantar Health: Kantar Health (now Kantar Profiles) provides broad healthcare market research, brand tracking, and patient/physician research to global pharma. Overlaps with Genactis in primary research and physician insights work but operates as part of a much wider portfolio including consumer research, brand strategy, and panel assets like LifePoints.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xx.com/Genactis

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genactis, Inc.